BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22118829)

  • 21. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
    Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
    Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
    Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
    Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of N-difluoromethyl-1,2-dihydropyrid-2-one acetic acid regioisomers: dual inhibitors of cyclooxygenases and 5-lipoxygenase.
    Yu G; Praveen Rao PN; Chowdhury MA; Abdellatif KR; Dong Y; Das D; Velázquez CA; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2168-73. PubMed ID: 20202839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors.
    Sadeghian H; Seyedi SM; Saberi MR; Arghiani Z; Riazi M
    Bioorg Med Chem; 2008 Jan; 16(2):890-901. PubMed ID: 17998164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
    Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
    Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase.
    Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New inhibitors of 5-lipoxygenase catalytic activity based on 2-(3-methylphenyl)propanoic acid and 4-substituted morpholine derivatives.
    Khayrullina VR; Taipov IA; Veselovsky AV; Shcherbinin DS; Gerchikov AY
    Biochemistry (Mosc); 2014 Apr; 79(4):376-84. PubMed ID: 24910210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
    Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
    Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of 1, 4-Dihydrothieno [3', 2':5, 6]thiopyrano[4, 3-c] pyrazole derivatives as human 5-Lipo-oxygenase inhibitors.
    Hu J; Zhu W; Meng H; Liu Y; Wang X; Hu C
    Chem Biol Drug Des; 2014 Dec; 84(6):642-7. PubMed ID: 24889744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
    Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
    Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and SAR studies of 4-allyoxyaniline amides as potent 15-lipoxygensae inhibitors.
    Seyedi SM; Eshghi H; Jafari Z; Attaran N; Sadeghian H; Saberi MR; Riazi MM
    Bioorg Med Chem; 2009 Feb; 17(4):1614-22. PubMed ID: 19157886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
    Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
    Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel ketoprofen amides--synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents.
    Rajić Z; Hadjipavlou-Litina D; Pontiki E; Kralj M; Suman L; Zorc B
    Chem Biol Drug Des; 2010 Jun; 75(6):641-52. PubMed ID: 20337784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
    Sukhorukov AY; Nirvanappa AC; Swamy J; Ioffe SL; Nanjunda Swamy S; Basappa ; Rangappa KS
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3618-21. PubMed ID: 24909082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling.
    Zheng M; Zheng M; Ye D; Deng Y; Qiu S; Luo X; Chen K; Liu H; Jiang H
    Bioorg Med Chem Lett; 2007 May; 17(9):2414-20. PubMed ID: 17336065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
    Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
    Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
    Hieke M; Rödl CB; Wisniewska JM; la Buscató E; Stark H; Schubert-Zsilavecz M; Steinhilber D; Hofmann B; Proschak E
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1969-75. PubMed ID: 22326163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.
    Chini MG; De Simone R; Bruno I; Riccio R; Dehm F; Weinigel C; Barz D; Werz O; Bifulco G
    Eur J Med Chem; 2012 Aug; 54():311-23. PubMed ID: 22683242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 1-(benzenesulfonamido)-2-[5-(N-hydroxypyridin-2(1H)-one)]acetylene regioisomers: a novel class of 5-lipoxygenase inhibitors.
    Chowdhury MA; Chen H; Abdellatif KR; Dong Y; Petruk KC; Knaus EE
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4195-8. PubMed ID: 18541424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.